Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 50 EP applications Emma Marie Bassinder has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 13, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13704563

SYSTEM FOR PROVIDING A LIQUID-SUBSTANCE MIXTURE ATTRACTIVE TO AN ANIMAL

IPC classification:
B65D 81/32, B65D 51/28
Applicant:
Novartis Tiergesundheit AG
Applicant:
Novartis AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Status:
PATENT GRANTED
EP13706128

METHODS AND COMPOSITIONS FOR REDUCING THE ENVIRONMENTAL IMPACT OF ANIMAL WASTE

IPC classification:
A23K 1/18, A23K 1/165
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
The patent has been granted
EP13721441

MAGNESIUM COMPOSITIONS FOR MODULATING THE PHARMACOKINETICS AND PHARMACODYNAMICS OF INSULIN AND INSULIN ANALOGS, AND INJECTION SITE PAIN

IPC classification:
A61K 47/18, A61K 47/12, A61K 47/02, A61K 38/28, A61K 9/00
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP13721733

TREATMENT OF FISH POPULATIONS WITH LUFENURON

IPC classification:
A61K 31/17, A01N 47/34, A61P 33/14
Applicant:
Novartis Tiergesundheit AG
Applicant:
Novartis AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Status:
PATENT GRANTED
EP13779364

BICYCLIC HETEROARYL CYCLOALKYLDIAMINE DERIVATIVES AS INHIBITORS OF SPLEEN TYROSINE KINASES (SYK)

IPC classification:
A61K 31/5025, C07D 471/04, A61P 37/00, A61P 35/00, A61P 29/00, A61P 11/00
Applicant:
Novartis Tiergesundheit AG
Applicant:
Novartis AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13747376

SUBTITUTED AZINES AS PESTICIDES

IPC classification:
A61K 31/506, A61K 31/505, A01P 17/00, A01N 43/54, C07D 487/10, C07D 413/14, C07D 403/14, C07D 403/12, C07D 403/04, C07D 401/14, C07D 401/12, C07D 401/04, C07D 239/48, C07D 239/47, C07D 213/74
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP13799490

NEW TREATMENT

IPC classification:
A01N 51/00
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13785745

AGGRECANASE INHIBITORS

IPC classification:
A61K 31/4166, C07D 233/76
Applicant:
Eli Lilly and Company Limited
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
The patent has been granted
EP13814903

AN ORAL IRON (III) BASED PHOSPHATE ADSORBENT FOR TREATING IRON-DEFICIENCY ANEMIA IN CATS WITH CHRONIC KIDNEY DISEASE

IPC classification:
A61K 33/26, A61P 7/06
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13815504

(HETERO) ARYLACRYLAMIDES FOR THE CONTROL OF ECTOPARASITES

IPC classification:
A01N 43/40, A01N 43/10, A01N 43/08, A01N 43/04, A01N 37/18
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP14712939

1 -HYDROXY-BENZOOXABOROLES AS ANTIPARASITIC AGENTS

IPC classification:
A01N 43/00, C07F 5/02
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
The patent has been granted
EP14784959

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
C07K 14/54, A61P 31/04, A61K 38/00
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14733933

PARASITICIDAL COMPOUNDS, METHODS, AND FORMULATIONS

IPC classification:
A61P 33/00, A61K 31/7048, C07H 17/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
GRANT OF PATENT INTENDED
EP15193269

NEW COMBINATION

IPC classification:
A61K 47/12, A61K 31/501, A61K 31/4184, A61K 9/20
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP14840710

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61K 38/20
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14860137

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61K 39/00
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14801989

New Compounds

IPC classification:
C07D 211/58, C07D 487/10, C07D 239/42, C07D 401/10, C07D 401/06, C07D 213/74, C07D 401/14
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP16188388

TREATMENT OF FISH POPULATIONS WITH LUFENURON

IPC classification:
A61K 9/50, A23K 50/80, A23K 20/105, A61P 33/14, A61K 31/17, A01N 47/34
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP15722319

INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL

IPC classification:
A61K 31/708, C07D 473/08
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15731204

TRANSDERMAL FORMULATIONS OF PERGOLIDE AND USES THEREOF

IPC classification:
A61K 31/48, A61K 47/40, A61K 9/08, A61K 47/22, A61K 47/20, A61K 47/16, A61K 47/14, A61K 47/10
Applicant:
Eli Lilly and Company Limited
Agent:
Cabinet Regimbeau
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP16195618

2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL

IPC classification:
A61P 17/02, A61P 17/06, A61P 29/00, A61K 31/522, C07D 487/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15760581

NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS

IPC classification:
A61K 31/18, A61P 33/10, C07C 311/20, C07C 311/08, C07C 205/11, C07D 213/61
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP15774806

INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL

IPC classification:
A61P 3/00, A61P 11/00, A61P 17/00, C07D 473/06, A61K 31/522
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15852286

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61K 38/20
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
Request for examination was made
EP15797744

DIARYL ISOXAZOLINE COMPOUND

IPC classification:
A01P 17/00, A01N 43/80, C07D 413/04
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP15805005

ANTIVIRAL EFFECTS OF NARASIN IN SWINE FEED

IPC classification:
A61P 1/12, A61K 31/351
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP15801597

1,2-BENZOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF KIDNEY DISORDERS

IPC classification:
A61P 3/10, A61P 13/12, A61K 31/428, C07D 417/06
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP15874258

METHODS OF IMPROVING YIELD IN RECOMBINANT PROTEIN PRODUCTION

IPC classification:
C07K 1/113, C07K 14/54
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
Request for examination was made
EP16731405

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61P 35/00, G01N 33/50, C07K 14/54, A61K 38/20
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
Request for examination was made
EP16732370

PEGYLATED INTERLEUKIN-10 FOR USE IN TREATING CANCER

IPC classification:
A61K 39/39
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
Request for examination was made
EP16721314

MONENSIN WATER DISPERSIBLE GRANULES BY WET GRANULATION

IPC classification:
A61K 31/351, A61K 9/16, A61K 9/00
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP16731449

2-OXO-1,3,8-TRIAZASPIRO[4.5]DECAN-3-YL]CARBOXYLIC ACID DERIVATIVES

IPC classification:
A61P 3/10, A61K 31/438, C07D 471/10
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP16829537

A PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN

IPC classification:
C07K 14/62, C07D 487/04, C07D 215/20, C07C 59/46, C07C 215/60, A61P 3/10, A61K 38/28, A61K 31/519, A61K 31/472, A61K 31/137, A61K 31/5578
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
ARC-IP sprl
Status:
Request for examination was made
EP16751123

CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61P 25/06, A61K 31/4439, C07D 401/12
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP16759905

CGRP RECEPTOR ANTAGONISTS

IPC classification:
C07D 487/04, A61K 31/519, A61K 31/4355, C07D 471/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP16840035

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61K 38/20
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
Request for examination was made
EP16785667

GLUCAGON RECEPTOR AGONISTS

IPC classification:
C07K 14/605, A61K 38/26
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP18155633

INSULIN FORMULATIONS FOR RAPID UPTAKE

IPC classification:
A61K 47/18, A61K 47/12, A61K 38/28
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Potter Clarkson LLP
Status:
Request for examination was made
EP16884214

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61K 38/00, C07K 14/54, A61P 35/00
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP16891935

GFRAL RECEPTOR THERAPIES

IPC classification:
A61P 3/10, A61P 3/08, A61P 3/04, A61K 39/395
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP17713108

COMBINATION THERAPY

IPC classification:
A61P 25/28, A61K 31/4439, C07D 401/10, A61K 39/395
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP17713104

COMBINATION THERAPY

IPC classification:
C07D 513/04, A61K 31/547, A61K 39/395, C07K 16/18
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP18176020

METHOD FOR ASSESSING PROTEIN IDENTITY AND STABILITY

IPC classification:
G01N 33/68, A61K 38/20
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP17725098

N-[3-[2-AMINO-5-(1,1-DIFLUOROETHYL)-4,4A,5,7-TETRAHYDROFURO[3,4-D][1,3]OXAZIN-7A-YL]-4-FLUORO-PHENYL]-5-(TRIFLUOROMETHYL)PYRIDINE-2-CARBOXAMIDE AND ITS (4AR,5S,7AS) ISOMER AS A SELECTIVE BACE1 INHIBITOR FOR TREATING E.G. ALZHEIMER'S DISEASE

IPC classification:
A61P 25/28, A61K 31/5365, C07D 498/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP17830434

CYCLOHEXYL BENZAMIDE COMPOUNDS

IPC classification:
A61P 3/10, A61K 31/4164, A61K 31/4245, C07D 233/02, C07D 249/08
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP17757632

COMBINATION THERAPY OF BACE-1 INHIBITOR AND ANTI-N3PGLU ABETA ANTIBODY

IPC classification:
C07D 513/04, C07K 16/18, A61K 31/542, A61K 39/395
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP17758400

1,4-OXAZINES USEFUL AS SELECTIVE BACE1 INHIBITORS

IPC classification:
A61P 25/28, A61K 31/437, A61K 31/4353, C07D 487/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP17797795

COMBINATION THERAPY

IPC classification:
C07D 513/04, A61P 25/28, A61K 31/542, A61K 31/541, A61K 31/166, A61K 39/00, C07K 16/18, A61K 39/395
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP19161129

RAPID-ACTING INSULIN COMPOSITIONS

IPC classification:
A61K 31/5585, A61K 38/28, A61P 3/10
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
The application has been published
EP17829372

COMPOSITIONS AND METHODS RELATED TO PYRIDINOYLPIPERIDINE 5-HT1F AGONISTS

IPC classification:
A61P 25/06, A61K 31/444, C07D 401/06
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made

Please Sign in to use this feature